The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

U.S. health secretary Robert F. Kennedy Jr. said on Wednesday that the "central focus" of the National Institutes of Health ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

The risk calculator shows improved precision in a population larger than the original dataset used to validate the tool.

Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

Investing.com -- Citi downgraded both AbbVie (NYSE: ABBV) and Merck (NSE: PROR) to Neutral in separate notes Wednesday, ...

A Rutgers institute celebrates 11 honorees using business for social good at its inaugural Corporate Social Innovation ...